NEW YORK, May 16, 2025 /PRNewswire/ -- Today, the FDA's approved the Lumipulse G pTau217/<BETA>-Amyloid 1-42 Plasma Ratio, marking a pivotal moment in the fight against Alzheimer's disease. This is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback